Efficacy, Safety, and Usability of Remifentanil as Premedication for INSURE in Preterm Neonates

Background: We previously reported a 67% extubation failure with INSURE (Intubation, Surfactant, Extubation) using morphine as analgosedative premedication. Remifentanil, a rapid- and short-acting narcotic, might be ideal for INSURE, but efficacy and safety data for this indication are limited. Obje...

Full description

Bibliographic Details
Main Authors: Hadiyah Y. Audil, Sara Tse, Chad Pezzano, Amy Mitchell-van Steele, Joaquim M. B. Pinheiro
Format: Article
Language:English
Published: MDPI AG 2018-05-01
Series:Children
Subjects:
Online Access:http://www.mdpi.com/2227-9067/5/5/63
id doaj-de6316e5e322403cba7eba9acd9c7ad7
record_format Article
spelling doaj-de6316e5e322403cba7eba9acd9c7ad72021-04-02T07:43:32ZengMDPI AGChildren2227-90672018-05-01556310.3390/children5050063children5050063Efficacy, Safety, and Usability of Remifentanil as Premedication for INSURE in Preterm NeonatesHadiyah Y. Audil0Sara Tse1Chad Pezzano2Amy Mitchell-van Steele3Joaquim M. B. Pinheiro4Albany Medical College, Albany, NY 12208, USADepartment of Pediatrics, Albany Medical College, MC-101, 47 New Scotland Avenue, Albany, NY 12208, USADepartment of Pediatrics, Albany Medical College, MC-101, 47 New Scotland Avenue, Albany, NY 12208, USADepartment of Pediatrics, Albany Medical College, MC-101, 47 New Scotland Avenue, Albany, NY 12208, USADepartment of Pediatrics, Albany Medical College, MC-101, 47 New Scotland Avenue, Albany, NY 12208, USABackground: We previously reported a 67% extubation failure with INSURE (Intubation, Surfactant, Extubation) using morphine as analgosedative premedication. Remifentanil, a rapid- and short-acting narcotic, might be ideal for INSURE, but efficacy and safety data for this indication are limited. Objectives: To assess whether remifentanil premedication increases extubation success rates compared with morphine, and to evaluate remifentanil’s safety and usability in a teaching hospital context. Methods: Retrospective review of remifentanil orders for premedication, at a large teaching hospital neonatal intensive care unit (NICU). We compared INSURE failure rates (needing invasive ventilation after INSURE) with prior morphine-associated rates. Additionally, we surveyed NICU staff to identify usability and logistic issues with remifentanil. Results: 73 remifentanil doses were administered to 62 neonates (mean 31.6 ± 3.8 weeks’ gestation). Extubation was successful in 88%, vs. 33% with morphine premedication (p < 0.001). Significant adverse events included chest wall rigidity (4%), one case of cardiopulmonary resuscitation (CPR) post-surfactant, naloxone reversal (5%), and notable transient desaturation (34%). Among 137 completed surveys, 57% indicated concerns, including delayed drug availability (median 1.1 h after order), rapid desaturations narrowing intubation timeframes and hindering trainee involvement, and difficulty with bag-mask ventilation after unsuccessful intubation attempts. Accordingly, 33% of ultimate intubators were attending neonatologists, versus 16% trainees. Conclusions: Remifentanil premedication was superior to morphine in allowing successful extubation, despite occasional chest wall rigidity and unfavorable conditions for trainees. We recommend direct supervision and INSURE protocols aimed at ensuring rapid intubation.http://www.mdpi.com/2227-9067/5/5/63remifentanilINSUREintubationsurfactantsedationpremedication
collection DOAJ
language English
format Article
sources DOAJ
author Hadiyah Y. Audil
Sara Tse
Chad Pezzano
Amy Mitchell-van Steele
Joaquim M. B. Pinheiro
spellingShingle Hadiyah Y. Audil
Sara Tse
Chad Pezzano
Amy Mitchell-van Steele
Joaquim M. B. Pinheiro
Efficacy, Safety, and Usability of Remifentanil as Premedication for INSURE in Preterm Neonates
Children
remifentanil
INSURE
intubation
surfactant
sedation
premedication
author_facet Hadiyah Y. Audil
Sara Tse
Chad Pezzano
Amy Mitchell-van Steele
Joaquim M. B. Pinheiro
author_sort Hadiyah Y. Audil
title Efficacy, Safety, and Usability of Remifentanil as Premedication for INSURE in Preterm Neonates
title_short Efficacy, Safety, and Usability of Remifentanil as Premedication for INSURE in Preterm Neonates
title_full Efficacy, Safety, and Usability of Remifentanil as Premedication for INSURE in Preterm Neonates
title_fullStr Efficacy, Safety, and Usability of Remifentanil as Premedication for INSURE in Preterm Neonates
title_full_unstemmed Efficacy, Safety, and Usability of Remifentanil as Premedication for INSURE in Preterm Neonates
title_sort efficacy, safety, and usability of remifentanil as premedication for insure in preterm neonates
publisher MDPI AG
series Children
issn 2227-9067
publishDate 2018-05-01
description Background: We previously reported a 67% extubation failure with INSURE (Intubation, Surfactant, Extubation) using morphine as analgosedative premedication. Remifentanil, a rapid- and short-acting narcotic, might be ideal for INSURE, but efficacy and safety data for this indication are limited. Objectives: To assess whether remifentanil premedication increases extubation success rates compared with morphine, and to evaluate remifentanil’s safety and usability in a teaching hospital context. Methods: Retrospective review of remifentanil orders for premedication, at a large teaching hospital neonatal intensive care unit (NICU). We compared INSURE failure rates (needing invasive ventilation after INSURE) with prior morphine-associated rates. Additionally, we surveyed NICU staff to identify usability and logistic issues with remifentanil. Results: 73 remifentanil doses were administered to 62 neonates (mean 31.6 ± 3.8 weeks’ gestation). Extubation was successful in 88%, vs. 33% with morphine premedication (p < 0.001). Significant adverse events included chest wall rigidity (4%), one case of cardiopulmonary resuscitation (CPR) post-surfactant, naloxone reversal (5%), and notable transient desaturation (34%). Among 137 completed surveys, 57% indicated concerns, including delayed drug availability (median 1.1 h after order), rapid desaturations narrowing intubation timeframes and hindering trainee involvement, and difficulty with bag-mask ventilation after unsuccessful intubation attempts. Accordingly, 33% of ultimate intubators were attending neonatologists, versus 16% trainees. Conclusions: Remifentanil premedication was superior to morphine in allowing successful extubation, despite occasional chest wall rigidity and unfavorable conditions for trainees. We recommend direct supervision and INSURE protocols aimed at ensuring rapid intubation.
topic remifentanil
INSURE
intubation
surfactant
sedation
premedication
url http://www.mdpi.com/2227-9067/5/5/63
work_keys_str_mv AT hadiyahyaudil efficacysafetyandusabilityofremifentanilaspremedicationforinsureinpretermneonates
AT saratse efficacysafetyandusabilityofremifentanilaspremedicationforinsureinpretermneonates
AT chadpezzano efficacysafetyandusabilityofremifentanilaspremedicationforinsureinpretermneonates
AT amymitchellvansteele efficacysafetyandusabilityofremifentanilaspremedicationforinsureinpretermneonates
AT joaquimmbpinheiro efficacysafetyandusabilityofremifentanilaspremedicationforinsureinpretermneonates
_version_ 1724170949609127936